Based on these studies, we speculate that the combination of ICA and CUR directly targets the DNMT1/IGFBP2 axis to affect cancer cell development and the level of PD-L1 to influence the differentiation of immune T cells, thereby affecting cancer cell development. The gene discussed is IGFBP2; the disease is cancer.